1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immuno-Oncology Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Immune Checkpoint Inhibitors
1.2.3 Monoclonal Antibodies
1.2.4 Cytokine-Based Immunotherapy
1.2.5 Cancer Vaccines
1.2.6 CAR-T Cell Therapy
1.3 Market by Application
1.3.1 Global Immuno-Oncology Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Center
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Immuno-Oncology Treatment Market Perspective (2017-2028)
2.2 Immuno-Oncology Treatment Growth Trends by Region
2.2.1 Immuno-Oncology Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Immuno-Oncology Treatment Historic Market Size by Region (2017-2022)
2.2.3 Immuno-Oncology Treatment Forecasted Market Size by Region (2023-2028)
2.3 Immuno-Oncology Treatment Market Dynamics
2.3.1 Immuno-Oncology Treatment Industry Trends
2.3.2 Immuno-Oncology Treatment Market Drivers
2.3.3 Immuno-Oncology Treatment Market Challenges
2.3.4 Immuno-Oncology Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Immuno-Oncology Treatment Players by Revenue
3.1.1 Global Top Immuno-Oncology Treatment Players by Revenue (2017-2022)
3.1.2 Global Immuno-Oncology Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Immuno-Oncology Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Immuno-Oncology Treatment Revenue
3.4 Global Immuno-Oncology Treatment Market Concentration Ratio
3.4.1 Global Immuno-Oncology Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immuno-Oncology Treatment Revenue in 2021
3.5 Immuno-Oncology Treatment Key Players Head office and Area Served
3.6 Key Players Immuno-Oncology Treatment Product Solution and Service
3.7 Date of Enter into Immuno-Oncology Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Immuno-Oncology Treatment Breakdown Data by Type
4.1 Global Immuno-Oncology Treatment Historic Market Size by Type (2017-2022)
4.2 Global Immuno-Oncology Treatment Forecasted Market Size by Type (2023-2028)
5 Immuno-Oncology Treatment Breakdown Data by Application
5.1 Global Immuno-Oncology Treatment Historic Market Size by Application (2017-2022)
5.2 Global Immuno-Oncology Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Immuno-Oncology Treatment Market Size (2017-2028)
6.2 North America Immuno-Oncology Treatment Market Size by Type
6.2.1 North America Immuno-Oncology Treatment Market Size by Type (2017-2022)
6.2.2 North America Immuno-Oncology Treatment Market Size by Type (2023-2028)
6.2.3 North America Immuno-Oncology Treatment Market Share by Type (2017-2028)
6.3 North America Immuno-Oncology Treatment Market Size by Application
6.3.1 North America Immuno-Oncology Treatment Market Size by Application (2017-2022)
6.3.2 North America Immuno-Oncology Treatment Market Size by Application (2023-2028)
6.3.3 North America Immuno-Oncology Treatment Market Share by Application (2017-2028)
6.4 North America Immuno-Oncology Treatment Market Size by Country
6.4.1 North America Immuno-Oncology Treatment Market Size by Country (2017-2022)
6.4.2 North America Immuno-Oncology Treatment Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Immuno-Oncology Treatment Market Size (2017-2028)
7.2 Europe Immuno-Oncology Treatment Market Size by Type
7.2.1 Europe Immuno-Oncology Treatment Market Size by Type (2017-2022)
7.2.2 Europe Immuno-Oncology Treatment Market Size by Type (2023-2028)
7.2.3 Europe Immuno-Oncology Treatment Market Share by Type (2017-2028)
7.3 Europe Immuno-Oncology Treatment Market Size by Application
7.3.1 Europe Immuno-Oncology Treatment Market Size by Application (2017-2022)
7.3.2 Europe Immuno-Oncology Treatment Market Size by Application (2023-2028)
7.3.3 Europe Immuno-Oncology Treatment Market Share by Application (2017-2028)
7.4 Europe Immuno-Oncology Treatment Market Size by Country
7.4.1 Europe Immuno-Oncology Treatment Market Size by Country (2017-2022)
7.4.2 Europe Immuno-Oncology Treatment Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Immuno-Oncology Treatment Market Size (2017-2028)
8.2 Asia-Pacific Immuno-Oncology Treatment Market Size by Type
8.2.1 Asia-Pacific Immuno-Oncology Treatment Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Immuno-Oncology Treatment Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Immuno-Oncology Treatment Market Share by Type (2017-2028)
8.3 Asia-Pacific Immuno-Oncology Treatment Market Size by Application
8.3.1 Asia-Pacific Immuno-Oncology Treatment Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Immuno-Oncology Treatment Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Immuno-Oncology Treatment Market Share by Application (2017-2028)
8.4 Asia-Pacific Immuno-Oncology Treatment Market Size by Region
8.4.1 Asia-Pacific Immuno-Oncology Treatment Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Immuno-Oncology Treatment Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Immuno-Oncology Treatment Market Size (2017-2028)
9.2 Latin America Immuno-Oncology Treatment Market Size by Type
9.2.1 Latin America Immuno-Oncology Treatment Market Size by Type (2017-2022)
9.2.2 Latin America Immuno-Oncology Treatment Market Size by Type (2023-2028)
9.2.3 Latin America Immuno-Oncology Treatment Market Share by Type (2017-2028)
9.3 Latin America Immuno-Oncology Treatment Market Size by Application
9.3.1 Latin America Immuno-Oncology Treatment Market Size by Application (2017-2022)
9.3.2 Latin America Immuno-Oncology Treatment Market Size by Application (2023-2028)
9.3.3 Latin America Immuno-Oncology Treatment Market Share by Application (2017-2028)
9.4 Latin America Immuno-Oncology Treatment Market Size by Country
9.4.1 Latin America Immuno-Oncology Treatment Market Size by Country (2017-2022)
9.4.2 Latin America Immuno-Oncology Treatment Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Immuno-Oncology Treatment Market Size (2017-2028)
10.2 Middle East & Africa Immuno-Oncology Treatment Market Size by Type
10.2.1 Middle East & Africa Immuno-Oncology Treatment Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Immuno-Oncology Treatment Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Immuno-Oncology Treatment Market Share by Type (2017-2028)
10.3 Middle East & Africa Immuno-Oncology Treatment Market Size by Application
10.3.1 Middle East & Africa Immuno-Oncology Treatment Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Immuno-Oncology Treatment Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Immuno-Oncology Treatment Market Share by Application (2017-2028)
10.4 Middle East & Africa Immuno-Oncology Treatment Market Size by Country
10.4.1 Middle East & Africa Immuno-Oncology Treatment Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Immuno-Oncology Treatment Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Details
11.1.2 Amgen Business Overview
11.1.3 Amgen Immuno-Oncology Treatment Introduction
11.1.4 Amgen Revenue in Immuno-Oncology Treatment Business (2017-2022)
11.1.5 Amgen Recent Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Immuno-Oncology Treatment Introduction
11.2.4 AstraZeneca Revenue in Immuno-Oncology Treatment Business (2017-2022)
11.2.5 AstraZeneca Recent Developments
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Details
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb Immuno-Oncology Treatment Introduction
11.3.4 Bristol-Myers Squibb Revenue in Immuno-Oncology Treatment Business (2017-2022)
11.3.5 Bristol-Myers Squibb Recent Developments
11.4 Eli-Lilly
11.4.1 Eli-Lilly Company Details
11.4.2 Eli-Lilly Business Overview
11.4.3 Eli-Lilly Immuno-Oncology Treatment Introduction
11.4.4 Eli-Lilly Revenue in Immuno-Oncology Treatment Business (2017-2022)
11.4.5 Eli-Lilly Recent Developments
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Immuno-Oncology Treatment Introduction
11.5.4 Roche Revenue in Immuno-Oncology Treatment Business (2017-2022)
11.5.5 Roche Recent Developments
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Details
11.6.2 GlaxoSmithKline Business Overview
11.6.3 GlaxoSmithKline Immuno-Oncology Treatment Introduction
11.6.4 GlaxoSmithKline Revenue in Immuno-Oncology Treatment Business (2017-2022)
11.6.5 GlaxoSmithKline Recent Developments
11.7 Janssen Biotech
11.7.1 Janssen Biotech Company Details
11.7.2 Janssen Biotech Business Overview
11.7.3 Janssen Biotech Immuno-Oncology Treatment Introduction
11.7.4 Janssen Biotech Revenue in Immuno-Oncology Treatment Business (2017-2022)
11.7.5 Janssen Biotech Recent Developments
11.8 Merck
11.8.1 Merck Company Details
11.8.2 Merck Business Overview
11.8.3 Merck Immuno-Oncology Treatment Introduction
11.8.4 Merck Revenue in Immuno-Oncology Treatment Business (2017-2022)
11.8.5 Merck Recent Developments
11.9 Novartis
11.9.1 Novartis Company Details
11.9.2 Novartis Business Overview
11.9.3 Novartis Immuno-Oncology Treatment Introduction
11.9.4 Novartis Revenue in Immuno-Oncology Treatment Business (2017-2022)
11.9.5 Novartis Recent Developments
11.10 Pfizer
11.10.1 Pfizer Company Details
11.10.2 Pfizer Business Overview
11.10.3 Pfizer Immuno-Oncology Treatment Introduction
11.10.4 Pfizer Revenue in Immuno-Oncology Treatment Business (2017-2022)
11.10.5 Pfizer Recent Developments
11.11 Sanofi
11.11.1 Sanofi Company Details
11.11.2 Sanofi Business Overview
11.11.3 Sanofi Immuno-Oncology Treatment Introduction
11.11.4 Sanofi Revenue in Immuno-Oncology Treatment Business (2017-2022)
11.11.5 Sanofi Recent Developments
11.12 Spectrum Pharmaceuticals
11.12.1 Spectrum Pharmaceuticals Company Details
11.12.2 Spectrum Pharmaceuticals Business Overview
11.12.3 Spectrum Pharmaceuticals Immuno-Oncology Treatment Introduction
11.12.4 Spectrum Pharmaceuticals Revenue in Immuno-Oncology Treatment Business (2017-2022)
11.12.5 Spectrum Pharmaceuticals Recent Developments
11.13 Takeda
11.13.1 Takeda Company Details
11.13.2 Takeda Business Overview
11.13.3 Takeda Immuno-Oncology Treatment Introduction
11.13.4 Takeda Revenue in Immuno-Oncology Treatment Business (2017-2022)
11.13.5 Takeda Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Immuno-Oncology Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Immune Checkpoint Inhibitors
Table 3. Key Players of Monoclonal Antibodies
Table 4. Key Players of Cytokine-Based Immunotherapy
Table 5. Key Players of Cancer Vaccines
Table 6. Key Players of CAR-T Cell Therapy
Table 7. Global Immuno-Oncology Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 8. Global Immuno-Oncology Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Immuno-Oncology Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Immuno-Oncology Treatment Market Share by Region (2017-2022)
Table 11. Global Immuno-Oncology Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Immuno-Oncology Treatment Market Share by Region (2023-2028)
Table 13. Immuno-Oncology Treatment Market Trends
Table 14. Immuno-Oncology Treatment Market Drivers
Table 15. Immuno-Oncology Treatment Market Challenges
Table 16. Immuno-Oncology Treatment Market Restraints
Table 17. Global Immuno-Oncology Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Immuno-Oncology Treatment Revenue Share by Players (2017-2022)
Table 19. Global Top Immuno-Oncology Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno-Oncology Treatment as of 2021)
Table 20. Ranking of Global Top Immuno-Oncology Treatment Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Immuno-Oncology Treatment Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Immuno-Oncology Treatment Product Solution and Service
Table 24. Date of Enter into Immuno-Oncology Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Immuno-Oncology Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Immuno-Oncology Treatment Revenue Market Share by Type (2017-2022)
Table 28. Global Immuno-Oncology Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Immuno-Oncology Treatment Revenue Market Share by Type (2023-2028)
Table 30. Global Immuno-Oncology Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Immuno-Oncology Treatment Revenue Share by Application (2017-2022)
Table 32. Global Immuno-Oncology Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Immuno-Oncology Treatment Revenue Share by Application (2023-2028)
Table 34. North America Immuno-Oncology Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 35. North America Immuno-Oncology Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 36. North America Immuno-Oncology Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 37. North America Immuno-Oncology Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 38. North America Immuno-Oncology Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 39. North America Immuno-Oncology Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 40. Europe Immuno-Oncology Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 41. Europe Immuno-Oncology Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 42. Europe Immuno-Oncology Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 43. Europe Immuno-Oncology Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 44. Europe Immuno-Oncology Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 45. Europe Immuno-Oncology Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 46. Asia Pacific Immuno-Oncology Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 47. Asia Pacific Immuno-Oncology Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 48. Asia Pacific Immuno-Oncology Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 49. Asia Pacific Immuno-Oncology Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 50. Asia Pacific Immuno-Oncology Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 51. Asia Pacific Immuno-Oncology Treatment Market Size by Region (2023-2028) & (US$ Million)
Table 52. Latin America Immuno-Oncology Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 53. Latin America Immuno-Oncology Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 54. Latin America Immuno-Oncology Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 55. Latin America Immuno-Oncology Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 56. Latin America Immuno-Oncology Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 57. Latin America Immuno-Oncology Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Immuno-Oncology Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Immuno-Oncology Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Immuno-Oncology Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Immuno-Oncology Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 62. Middle East and Africa Immuno-Oncology Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 63. Middle East and Africa Immuno-Oncology Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 64. Amgen Company Details
Table 65. Amgen Business Overview
Table 66. Amgen Immuno-Oncology Treatment Product
Table 67. Amgen Revenue in Immuno-Oncology Treatment Business (2017-2022) & (US$ Million)
Table 68. Amgen Recent Developments
Table 69. AstraZeneca Company Details
Table 70. AstraZeneca Business Overview
Table 71. AstraZeneca Immuno-Oncology Treatment Product
Table 72. AstraZeneca Revenue in Immuno-Oncology Treatment Business (2017-2022) & (US$ Million)
Table 73. AstraZeneca Recent Developments
Table 74. Bristol-Myers Squibb Company Details
Table 75. Bristol-Myers Squibb Business Overview
Table 76. Bristol-Myers Squibb Immuno-Oncology Treatment Product
Table 77. Bristol-Myers Squibb Revenue in Immuno-Oncology Treatment Business (2017-2022) & (US$ Million)
Table 78. Bristol-Myers Squibb Recent Developments
Table 79. Eli-Lilly Company Details
Table 80. Eli-Lilly Business Overview
Table 81. Eli-Lilly Immuno-Oncology Treatment Product
Table 82. Eli-Lilly Revenue in Immuno-Oncology Treatment Business (2017-2022) & (US$ Million)
Table 83. Eli-Lilly Recent Developments
Table 84. Roche Company Details
Table 85. Roche Business Overview
Table 86. Roche Immuno-Oncology Treatment Product
Table 87. Roche Revenue in Immuno-Oncology Treatment Business (2017-2022) & (US$ Million)
Table 88. Roche Recent Developments
Table 89. GlaxoSmithKline Company Details
Table 90. GlaxoSmithKline Business Overview
Table 91. GlaxoSmithKline Immuno-Oncology Treatment Product
Table 92. GlaxoSmithKline Revenue in Immuno-Oncology Treatment Business (2017-2022) & (US$ Million)
Table 93. GlaxoSmithKline Recent Developments
Table 94. Janssen Biotech Company Details
Table 95. Janssen Biotech Business Overview
Table 96. Janssen Biotech Immuno-Oncology Treatment Product
Table 97. Janssen Biotech Revenue in Immuno-Oncology Treatment Business (2017-2022) & (US$ Million)
Table 98. Janssen Biotech Recent Developments
Table 99. Merck Company Details
Table 100. Merck Business Overview
Table 101. Merck Immuno-Oncology Treatment Product
Table 102. Merck Revenue in Immuno-Oncology Treatment Business (2017-2022) & (US$ Million)
Table 103. Merck Recent Developments
Table 104. Novartis Company Details
Table 105. Novartis Business Overview
Table 106. Novartis Immuno-Oncology Treatment Product
Table 107. Novartis Revenue in Immuno-Oncology Treatment Business (2017-2022) & (US$ Million)
Table 108. Novartis Recent Developments
Table 109. Pfizer Company Details
Table 110. Pfizer Business Overview
Table 111. Pfizer Immuno-Oncology Treatment Product
Table 112. Pfizer Revenue in Immuno-Oncology Treatment Business (2017-2022) & (US$ Million)
Table 113. Pfizer Recent Developments
Table 114. Sanofi Company Details
Table 115. Sanofi Business Overview
Table 116. Sanofi Immuno-Oncology Treatment Product
Table 117. Sanofi Revenue in Immuno-Oncology Treatment Business (2017-2022) & (US$ Million)
Table 118. Sanofi Recent Developments
Table 119. Spectrum Pharmaceuticals Company Details
Table 120. Spectrum Pharmaceuticals Business Overview
Table 121. Spectrum Pharmaceuticals Immuno-Oncology Treatment Product
Table 122. Spectrum Pharmaceuticals Revenue in Immuno-Oncology Treatment Business (2017-2022) & (US$ Million)
Table 123. Spectrum Pharmaceuticals Recent Developments
Table 124. Takeda Company Details
Table 125. Takeda Business Overview
Table 126. Takeda Immuno-Oncology Treatment Product
Table 127. Takeda Revenue in Immuno-Oncology Treatment Business (2017-2022) & (US$ Million)
Table 128. Takeda Recent Developments
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Immuno-Oncology Treatment Market Share by Type: 2021 VS 2028
Figure 2. Immune Checkpoint Inhibitors Features
Figure 3. Monoclonal Antibodies Features
Figure 4. Cytokine-Based Immunotherapy Features
Figure 5. Cancer Vaccines Features
Figure 6. CAR-T Cell Therapy Features
Figure 7. Global Immuno-Oncology Treatment Market Share by Application: 2021 VS 2028
Figure 8. Hospitals Case Studies
Figure 9. Ambulatory Surgical Center Case Studies
Figure 10. Others Case Studies
Figure 11. Immuno-Oncology Treatment Report Years Considered
Figure 12. Global Immuno-Oncology Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Immuno-Oncology Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Immuno-Oncology Treatment Market Share by Region: 2021 VS 2028
Figure 15. Global Immuno-Oncology Treatment Market Share by Players in 2021
Figure 16. Global Top Immuno-Oncology Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno-Oncology Treatment as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Immuno-Oncology Treatment Revenue in 2021
Figure 18. North America Immuno-Oncology Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 19. North America Immuno-Oncology Treatment Market Size Market Share by Type (2017-2028)
Figure 20. North America Immuno-Oncology Treatment Market Size Market Share by Application (2017-2028)
Figure 21. North America Immuno-Oncology Treatment Market Size Share by Country (2017-2028)
Figure 22. United States Immuno-Oncology Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Canada Immuno-Oncology Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Immuno-Oncology Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 25. Europe Immuno-Oncology Treatment Market Size Market Share by Type (2017-2028)
Figure 26. Europe Immuno-Oncology Treatment Market Size Market Share by Application (2017-2028)
Figure 27. Europe Immuno-Oncology Treatment Market Size Share by Country (2017-2028)
Figure 28. Germany Immuno-Oncology Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. France Immuno-Oncology Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. U.K. Immuno-Oncology Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Italy Immuno-Oncology Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Russia Immuno-Oncology Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Nordic Countries Immuno-Oncology Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Immuno-Oncology Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 35. Asia Pacific Immuno-Oncology Treatment Market Size Market Share by Type (2017-2028)
Figure 36. Asia Pacific Immuno-Oncology Treatment Market Size Market Share by Application (2017-2028)
Figure 37. Asia Pacific Immuno-Oncology Treatment Market Size Share by Region (2017-2028)
Figure 38. China Immuno-Oncology Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Japan Immuno-Oncology Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. South Korea Immuno-Oncology Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Southeast Asia Immuno-Oncology Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. India Immuno-Oncology Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Australia Immuno-Oncology Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 44. Latin America Immuno-Oncology Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 45. Latin America Immuno-Oncology Treatment Market Size Market Share by Type (2017-2028)
Figure 46. Latin America Immuno-Oncology Treatment Market Size Market Share by Application (2017-2028)
Figure 47. Latin America Immuno-Oncology Treatment Market Size Share by Country (2017-2028)
Figure 48. Mexico Immuno-Oncology Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Brazil Immuno-Oncology Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Middle East & Africa Immuno-Oncology Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 51. Middle East and Africa Immuno-Oncology Treatment Market Size Market Share by Type (2017-2028)
Figure 52. Middle East and Africa Immuno-Oncology Treatment Market Size Market Share by Application (2017-2028)
Figure 53. Middle East and Africa Immuno-Oncology Treatment Market Size Share by Country (2017-2028)
Figure 54. Turkey Immuno-Oncology Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Saudi Arabia Immuno-Oncology Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. UAE Immuno-Oncology Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. Amgen Revenue Growth Rate in Immuno-Oncology Treatment Business (2017-2022)
Figure 58. AstraZeneca Revenue Growth Rate in Immuno-Oncology Treatment Business (2017-2022)
Figure 59. Bristol-Myers Squibb Revenue Growth Rate in Immuno-Oncology Treatment Business (2017-2022)
Figure 60. Eli-Lilly Revenue Growth Rate in Immuno-Oncology Treatment Business (2017-2022)
Figure 61. Roche Revenue Growth Rate in Immuno-Oncology Treatment Business (2017-2022)
Figure 62. GlaxoSmithKline Revenue Growth Rate in Immuno-Oncology Treatment Business (2017-2022)
Figure 63. Janssen Biotech Revenue Growth Rate in Immuno-Oncology Treatment Business (2017-2022)
Figure 64. Merck Revenue Growth Rate in Immuno-Oncology Treatment Business (2017-2022)
Figure 65. Novartis Revenue Growth Rate in Immuno-Oncology Treatment Business (2017-2022)
Figure 66. Pfizer Revenue Growth Rate in Immuno-Oncology Treatment Business (2017-2022)
Figure 67. Sanofi Revenue Growth Rate in Immuno-Oncology Treatment Business (2017-2022)
Figure 68. Spectrum Pharmaceuticals Revenue Growth Rate in Immuno-Oncology Treatment Business (2017-2022)
Figure 69. Takeda Revenue Growth Rate in Immuno-Oncology Treatment Business (2017-2022)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
